Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
Saved in:
| Title: | Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma. |
|---|---|
| Authors: | Messinger D; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Harris MK; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Cummings JR; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Thomas C; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Yang T; Department of Neurology, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Sweha SR; Department of Pathology, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Woo R; Cancer Research, California Pacific Medical Center Research Institute; San Francisco, California, USA., Siddaway R; Arthur and Sonia Labatt Brain Tumour Research Centre and Division of Pathology, Hospital for Sick Children, Toronto, Canada., Burkert M; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway., Stallard S; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Qin T; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, USA., Mullan B; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Siada R; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Ravindran R; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Niculcea M; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Dowling AR; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Bradin J; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Ginn KF; Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA., Gener MAH; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA., Dorris K; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Vitanza NA; Department of Pediatrics, Seattle Children's, Seattle, Washington, USA., Schmidt SV; Institute of Innate Immunity, AG Immunogenomics, University Bonn, Bonn, Germany., Spitzer J; Institute of Innate Immunity, AG Immunogenomics, University Bonn, Bonn, Germany., Li J; Dana-Farber Boston Children's Cancer and Blood Disorders Center, Department of Pediatric Oncology, Boston, Massachusetts, USA., Filbin MG; Dana-Farber Boston Children's Cancer and Blood Disorders Center, Department of Pediatric Oncology, Boston, Massachusetts, USA., Cao X; Department of Pathology, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Castro MG; Department of Neurosurgery, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Lowenstein PR; Department of Neurosurgery, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA.; Department of Cell and Developmental Biology, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Mody R; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Chinnaiyan A; Department of Pathology, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Desprez PY; Cancer Research, California Pacific Medical Center Research Institute; San Francisco, California, USA., McAllister S; Cancer Research, California Pacific Medical Center Research Institute; San Francisco, California, USA., Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan NSW, Australia., Hawkins C; Arthur and Sonia Labatt Brain Tumour Research Centre and Division of Pathology, Hospital for Sick Children, Toronto, Canada., Waszak SM; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; Division of Pediatric and Adolescent Medicine, Department of Pediatric Research, Rikshospitalet, Oslo University Hospital, Oslo, Norway., Venneti S; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Koschmann C; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Michigan Medical School (UMMS), Ann Arbor, Michigan, USA., Yadav VN; Department of Pediatrics at Children's Mercy Research Institute, Kansas City, Missouri, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2023 Jan 05; Vol. 25 (1), pp. 54-67. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noac141 |
